Myriad Genetics, Inc (NASDAQ:MYGN) has a beta value of 1.85 and has seen 4.13 million shares traded in the last trading session. The company, currently
During the last session, Myriad Genetics, Inc (NASDAQ:MYGN)’s traded shares were 1.66 million, with the beta value of the company hitting 1.87. At the end
In the last trading session, 1.61 million shares of the Myriad Genetics, Inc (NASDAQ:MYGN) were traded, and its beta was 1.89. Most recently the company’s
In the last trading session, 1.82 million Myriad Genetics, Inc (NASDAQ:MYGN) shares changed hands as the company’s beta touched 1.81. With the company’s per share
Myriad Genetics, Inc (NASDAQ:MYGN) has a beta value of 2.03 and has seen 3.67 million shares traded in the last trading session. The company, currently
During the last session, Myriad Genetics, Inc (NASDAQ:MYGN)’s traded shares were 7.28 million, with the beta value of the company hitting 2.05. At the end
Myriad Genetics, Inc (NASDAQ:MYGN)’s traded shares stood at 4.22 million during the last session, with the company’s beta value hitting 2.02. At the close of
In the latest trading session,, 0.44 million Myriad Genetics, Inc (NASDAQ:MYGN) shares changed hands as the company’s beta touched 2.02. With the company’s most recent
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne